+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application, By End User, By Region

  • PDF Icon

    Report

  • 111 Pages
  • December 2022
  • Region: Global
  • TechSci Research
  • ID: 5697770
Free Webex Call
10% Free customization
Description Jump to:

Increasing Application of Natural Killer Cells for the Treatment of Various Disease Including Liver Diseases, Infections, Cancer, Among Others is Expected to Drive the Growth of Global Natural Killer Cells Therapeutics Market in the Forecast Period

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global natural killer cells therapeutics market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to growing patient pool suffering from various chronic diseases such as cancer, cardiovascular diseases, diabetes, among others. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This has increased the demand for effective treatment options for finding a cure for cancer, thereby driving the growth of global natural killer cells therapeutics market. Additionally, growing focus of biotechnology & pharmaceutical companies and academic & research institutions across the globe for developing cost effective and potent treatments for different chronic diseases is expected to create lucrative opportunities for the market growth in the coming years. These companies and research organizations are conducting research & development activities and launching clinical trials in search of a potential natural killer cells therapeutics solution for different chronic and acute diseases. According, to clinicaltrials.gov, there are around 199 clinical trials related to natural killer cells are in some phase of development worldwide.

Application of the Natural Killer Cells in Treatment of Critical Diseases

Increasing application of natural killer cells for the treatment of various disease including liver diseases, infections, cancer, among others is expected to drive the growth of global natural killer cells therapeutics market in the forecast period. In addition to this, the natural killer cells play a pivotal role in the immune surveillance of tumor. This in turn is leading to the widespread adoption of natural killer cells therapeutics across the world. Besides, natural killer cells have specific attaching ability and ability to discard stressed cells. All these benefits associated with natural killer cells is expected to drive the growth of global natural killer cells therapeutics market during the forecast period.

Rise in Awareness about Immunotherapies

The prevalence of cancer has increased worldwide over the years and the available treatment options are not that efficient since a lot of instances of reoccurrence of tumours has been witnessed, arising the need for development of an effective and permanent treatment. Immunotherapies have gained much attention in recent years to treat different malignancies. Among all the immunotherapies, CAR -T cell therapies have been studied and were used but have various limitations that led to the development of natural killer (NK) cell therapies. Growing the awareness among the population about various immunotherapies and increase in research and development of bi-specific antibody for engaging natural killer cells to eliminate tumor cells are driving the global natural killer (NK) cell therapeutics market.

Market Segmentation

The global natural killer cells therapeutics market can be segmented by type, by application, by end use, and by region. Based on type, the market can be segmented into natural killer cell therapies and natural killer cell directed antibodies. Based on application, the market can be differentiated into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. Based on end user, the market can be categorized into hospitals & clinics, academic & research institutions, and others. Regionally, North America dominated the global natural killer cells therapeutics market followed by Europe, Asia Pacific, South America, and Middle East & Africa region. In terms of countries, United States dominated the global natural killer cells therapeutics market in 2021 and is expected to maintain its dominance during the forecast period on account of growing prevalence of different chronic diseases in the country. According to the global cancer observatory, around 2,281,658 new cancer cases were reported in the United States in 2020.

Market Players

Affimed N.V., Century Therapeutics, Inc., Celularity Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., Fate Therapeutics, Inc., Gamida Cell Ltd., ImmunityBio, Inc., Innate Pharma SA , Nkarta, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited , VaxCell Biotherapeutics Co., Ltd., Acepodia Inc., Glycostem Therapeutics B.V., among others are some of the leading players operating in the global natural killer cells therapeutics market.

Report Scope:

In this report, global natural killer cells therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Natural Killer Cells Therapeutics Market, By Type:

  • Natural Killer Cell Therapies
  • Natural Killer Cell Directed Antibodies

Natural Killer Cells Therapeutics Market, By Application:

  • Cancer
  • Gastrointestinal Diseases
  • Immunoproliferative Disorders
  • Others

Natural Killer Cells Therapeutics Market, By End User:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Others

Natural Killer Cells Therapeutics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Natural Killer Cells Therapeutics Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on Global Natural Killer Cells Therapeutics Market5. Voice of Customer6. Clinical Trial Analysis
7. Global Natural Killer Cells Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies)
7.2.2. By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others)
7.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
7.2.4. By Region
7.2.5. By Company (2021)
7.3. Market Map
8. North America Natural Killer Cells Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Natural Killer Cells Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Canada Natural Killer Cells Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Mexico Natural Killer Cells Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By End User
9. Europe Natural Killer Cells Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Europe: Country Analysis
9.3.1. France Natural Killer Cells Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Germany Natural Killer Cells Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. United Kingdom Natural Killer Cells Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. Italy Natural Killer Cells Therapeutics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Spain Natural Killer Cells Therapeutics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Type
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. Asia-Pacific Natural Killer Cells Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. Asia-Pacific: Country Analysis
10.3.1. China Natural Killer Cells Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. India Natural Killer Cells Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Japan Natural Killer Cells Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By End User
10.3.4. South Korea Natural Killer Cells Therapeutics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Application
10.3.4.2.3. By End User
10.3.5. Australia Natural Killer Cells Therapeutics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Type
10.3.5.2.2. By Application
10.3.5.2.3. By End User
11. South America Natural Killer Cells Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Application
11.2.3. By End User
11.2.4. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Natural Killer Cells Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Argentina Natural Killer Cells Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. Colombia Natural Killer Cells Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type
11.3.3.2.2. By Application
11.3.3.2.3. By End User
12. Middle East and Africa Natural Killer Cells Therapeutics Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By Application
12.2.3. By End User
12.2.4. By Country
12.3. MEA: Country Analysis
12.3.1. South Africa Natural Killer Cells Therapeutics Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Type
12.3.1.2.2. By Application
12.3.1.2.3. By End User
12.3.2. Saudi Arabia Natural Killer Cells Therapeutics Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Type
12.3.2.2.2. By Application
12.3.2.2.3. By End User
12.3.3. UAE Natural Killer Cells Therapeutics Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Type
12.3.3.2.2. By Application
12.3.3.2.3. By End User
12.3.4. Turkey Natural Killer Cells Therapeutics Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Type
12.3.4.2.2. By Application
12.3.4.2.3. By End User
12.3.5. Egypt Natural Killer Cells Therapeutics Market Outlook
12.3.5.1. Market Size & Forecast
12.3.5.1.1. By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1. By Type
12.3.5.2.2. By Application
12.3.5.2.3. By End User
13. Market Dynamics
13.1. Drivers
13.2. Challenges
14. Market Trends & Developments
15. Competitive Landscape
15.1. Affimed N.V.
15.2. Century Therapeutics, Inc.
15.3. Celularity Inc.
15.4. Cytovac A/S
15.5. Dragonfly Therapeutics, Inc.
15.6. Fate Therapeutics, Inc.
15.7. Gamida Cell Ltd.
15.8. ImmunityBio, Inc.
15.9. Innate Pharma SA
15.10. Nkarta, Inc.
15.11. Sanofi S.A.
15.12. Takeda Pharmaceutical Company Limited
15.13. VaxCell Biotherapeutics Co., Ltd.
15.14. Acepodia Inc.
15.15. Glycostem Therapeutics B.V.
16. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Affimed N.V.
  • Century Therapeutics, Inc.
  • Celularity Inc.
  • Cytovac A/S
  • Dragonfly Therapeutics, Inc.
  • Fate Therapeutics, Inc.
  • Gamida Cell Ltd.
  • ImmunityBio, Inc.
  • Innate Pharma SA
  • Nkarta, Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • VaxCell Biotherapeutics Co., Ltd.
  • Acepodia Inc.
  • Glycostem Therapeutics B.V.

Related Topics

Related Reports

Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027 - Product Image

Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027

  • Report
  • 210 Pages
  • Global
From
Global Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Forecast 2024-2030 - Product Image

Global Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Natural Killer Cell Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Natural Killer Cell Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 83 Pages
  • Global
From
Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 138 Pages
  • Global
From
iPSC derived NK cells - Pipeline Insight, 2024 - Product Image

iPSC derived NK cells - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.